GlassScriptPhysician profile
Aimee Hurd
NPI 1225457310
$2,198.50
in general payments reported to CMS, 2019-2025
23 companies · $576 in 2025
The $576 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.84 · 2022: $380 · 2023: $402 · 2024: $769 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $424.64 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $238.93 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $232.56 | 2021-2024 | |
| Pfizer INC. | $229.79 | 2022-2025 | |
| Glaxosmithkline, LLC. | $227.53 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $195.61 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $89.51 | 2023-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $75.60 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.08 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.49 | 2024-2025 | Xifaxan |
| Astellas Pharma US INC | $53.36 | 2023-2024 | Veozah |
| Eisai INC. | $52.37 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $49.60 | 2024-2025 | Givlaari |
| Inogen, INC. | $40.38 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ardelyx, INC. | $24.58 | 2025 | Ibsrela |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $22.88 | 2021 | |
| Xeris Pharmaceuticals, INC. | $20.94 | 2022 | |
| Philips North America LLC | $19.92 | 2024 | (Ck7) Extended Holter |
| Dexcom, INC. | $18.52 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.16 | 2022 | |
| Sumitomo Pharma America, INC. | $16.94 | 2024 | Gemtesa |
| Exact Sciences Corporation | $15.38 | 2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $11.73 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Hurd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.